Luca F Maschião1, Francisco I Bastos2, Erin Wilson3, Willi McFarland4, Caitlin Turner3, Thiago Pestana5, Maria Amélia Veras1. 1. Departamento de Saúde Coletiva, Faculdade de Ciências Médicas da Santa Casa de São Paulo, São Paulo, Brazil. 2. Laboratório de Informação em Saúde, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil. 3. San Francisco Department of Public Health, San Francisco, California, USA. 4. Department of Epidemiology, University of California, San Francisco, California, USA. 5. Programa de Pós-Graduação em Epidemiologia da Faculdade de Saúde Pública, Universidade de São Paulo, São Paulo, Brazil.
Abstract
Purpose: Trans women are systematically excluded from basic human rights, possibly due to social contexts of transphobia. In health care, such barriers may result in nonprescribed sex hormone use and lead to significant health complications. As few studies investigated this phenomenon, we analyzed factors associated with nonprescribed sex hormone use by trans women in seven municipalities of São Paulo, Brazil. Methods: Muriel was a cross-sectional study (2014/2015), in which 673 transgender people answered a face-to-face survey. This analysis focused on trans women (n=616). Poisson regression models were used to assess factors associated with nonprescribed sex hormone use. A direct acyclic graph was built with a priori knowledge on the matter and was used for covariate selection. Results: A total of 90.7% of participants reported ever taking sex hormones. Most of those detailed nonprescribed use, which was associated with sex work, starting to use hormones before 18, identifying as travesti and lower education. Having the chosen name honored in public health services was found to be protective against this outcome. Conclusion: A high proportion of nonprescribed sex hormone use was observed in our sample. Our findings suggest barriers to health care and the need for trans women to resort to medically unsupervised transition procedures. Among sex workers, this may also be due to higher economic and access needs than other groups. Ensuring social rights and providing adequate health care services may lessen nonprescribed sex hormone use, preventing subsequent risks and resulting in better health outcomes for trans women. Copyright 2020, Mary Ann Liebert, Inc., publishers.
Purpose: Trans women are systematically excluded from basic human rights, possibly due to social contexts of transphobia. In health care, such barriers may result in nonprescribed sex hormone use and lead to significant health complications. As few studies investigated this phenomenon, we analyzed factors associated with nonprescribed sex hormone use by trans women in seven municipalities of São Paulo, Brazil. Methods: Muriel was a cross-sectional study (2014/2015), in which 673 transgender people answered a face-to-face survey. This analysis focused on trans women (n=616). Poisson regression models were used to assess factors associated with nonprescribed sex hormone use. A direct acyclic graph was built with a priori knowledge on the matter and was used for covariate selection. Results: A total of 90.7% of participants reported ever taking sex hormones. Most of those detailed nonprescribed use, which was associated with sex work, starting to use hormones before 18, identifying as travesti and lower education. Having the chosen name honored in public health services was found to be protective against this outcome. Conclusion: A high proportion of nonprescribed sex hormone use was observed in our sample. Our findings suggest barriers to health care and the need for trans women to resort to medically unsupervised transition procedures. Among sex workers, this may also be due to higher economic and access needs than other groups. Ensuring social rights and providing adequate health care services may lessen nonprescribed sex hormone use, preventing subsequent risks and resulting in better health outcomes for trans women. Copyright 2020, Mary Ann Liebert, Inc., publishers.
Entities:
Keywords:
discrimination; hormone; public policies; syndemics; transgender women
Authors: Sari L Reisner; Tonia Poteat; JoAnne Keatley; Mauro Cabral; Tampose Mothopeng; Emilia Dunham; Claire E Holland; Ryan Max; Stefan D Baral Journal: Lancet Date: 2016-06-17 Impact factor: 79.321
Authors: Wylie C Hembree; Peggy T Cohen-Kettenis; Louis Gooren; Sabine E Hannema; Walter J Meyer; M Hassan Murad; Stephen M Rosenthal; Joshua D Safer; Vin Tangpricha; Guy G T'Sjoen Journal: J Clin Endocrinol Metab Date: 2017-11-01 Impact factor: 5.958
Authors: Henk Asscheman; Erik J Giltay; Jos A J Megens; W Pim de Ronde; Michael A A van Trotsenburg; Louis J G Gooren Journal: Eur J Endocrinol Date: 2011-01-25 Impact factor: 6.664